Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Combined effects of the angiogenic genes polymorphisms on prostate cancer susceptibility and aggressiveness.

Sfar S, Saad H, Mosbah F, Chouchane L.

Mol Biol Rep. 2009 Jan;36(1):37-45. Epub 2007 Oct 5.

PMID:
17917789
2.

TSP1 and MMP9 genetic variants in sporadic prostate cancer.

Sfar S, Saad H, Mosbah F, Gabbouj S, Chouchane L.

Cancer Genet Cytogenet. 2007 Jan 1;172(1):38-44.

PMID:
17175378
3.

Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.

Sfar S, Hassen E, Saad H, Mosbah F, Chouchane L.

Cytokine. 2006 Jul;35(1-2):21-8. Epub 2006 Sep 5. Erratum in: Cytokine. 2006 Nov;36(3-4):199-200.

PMID:
16908180
4.

Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.

Sfar S, Saad H, Mosbah F, Chouchane L.

Hum Immunol. 2010 Apr;71(4):377-82. doi: 10.1016/j.humimm.2010.01.017. Epub 2010 Feb 4.

PMID:
20096741
5.

Associations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysis.

Xu Y, Zhu S.

Tumour Biol. 2014 Feb;35(2):1307-11. doi: 10.1007/s13277-013-1173-5. Epub 2013 Oct 15.

PMID:
24127038
6.

Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.

Jang MJ, Kim JW, Jeon YJ, Chong SY, Oh D, Kim NK.

Int J Clin Oncol. 2013 Dec;18(6):1032-41. doi: 10.1007/s10147-012-0493-6. Epub 2012 Nov 7.

PMID:
23132736
7.

Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.

Dos Reis ST, Pontes J Jr, Villanova FE, Borra PM, Antunes AA, Dall'oglio MF, Srougi M, Leite KR.

J Urol. 2009 May;181(5):2320-5. doi: 10.1016/j.juro.2009.01.012. Epub 2009 Mar 19. Erratum in: J Urol. 2009 Jul;182(1):400.

PMID:
19303106
8.

Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma.

Brito AB, Lourenço GJ, Oliveira GB, De Souza CA, Vassallo J, Lima CS.

Ann Hematol. 2014 Aug;93(8):1363-9. doi: 10.1007/s00277-014-2062-8. Epub 2014 Apr 1.

PMID:
24687381
9.

Combined effect of vascular endothelial growth factor and its receptor polymorphisms in endometriosis: a case-control study.

Cardoso JV, Abrão MS, Vianna-Jorge R, Ferrari R, Berardo PT, Machado DE, Perini JA.

Eur J Obstet Gynecol Reprod Biol. 2017 Feb;209:25-33. doi: 10.1016/j.ejogrb.2016.10.046. Epub 2016 Oct 29.

PMID:
27836223
10.

Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk.

VanCleave TT, Moore JH, Benford ML, Brock GN, Kalbfleisch T, Baumgartner RN, Lillard JW Jr, Kittles RA, Kidd LC.

Prostate. 2010 Mar 1;70(4):341-52. doi: 10.1002/pros.21067.

11.

Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.

Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamula J, Pekala W, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Hallmans G, Försti A.

Clin Cancer Res. 2005 May 15;11(10):3647-53.

12.

Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans.

Jang MJ, Jeon YJ, Kim JW, Cho YK, Lee SK, Hwang SG, Oh D, Kim NK.

Mol Carcinog. 2013 Nov;52 Suppl 1:E60-9. doi: 10.1002/mc.21980. Epub 2012 Nov 20.

PMID:
23169005
13.

Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk.

Hofmann G, Langsenlehner U, Renner W, Langsenlehner T, Yazdani-Biuki B, Clar H, Gerger A, Wehrschuetz M, Samonigg H, Krippl P.

J Cancer Res Clin Oncol. 2008 May;134(5):591-5. Epub 2007 Oct 16.

PMID:
17938959
14.

Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressiveness.

Sa-Nguanraksa D, Chuangsuwanich T, Pongpruttipan T, Kummalue T, Rojananin S, Ratanawichhitrasin A, Prasarttong-Osoth P, Chuthatisith S, Pisarnturakit P, Aeumrithaicharoenchok W, Rushatamukayanunt P, Lohsiriwat V, Boonsripitayanon M, Malasit P, O-Charoenrat P.

Mol Med Rep. 2013 Oct;8(4):1242-50. doi: 10.3892/mmr.2013.1607. Epub 2013 Jul 31.

PMID:
23904001
15.

Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.

Langsenlehner T, Thurner EM, Renner W, Gerger A, Kapp KS, Langsenlehner U.

Strahlenther Onkol. 2014 Apr;190(4):364-9. doi: 10.1007/s00066-013-0503-2. Epub 2014 Jan 18.

PMID:
24435801
16.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
17.

Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.

Fukuda H, Tsuchiya N, Narita S, Kumazawa T, Horikawa Y, Inoue T, Saito M, Yuasa T, Matsuura S, Satoh S, Ogawa O, Habuchi T.

Oncol Rep. 2007 Nov;18(5):1155-63.

PMID:
17914566
18.

Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer.

Chae YS, Kim JG, Sohn SK, Cho YY, Ahn BM, Moon JH, Jeon SW, Park JY, Lee IT, Choi GS, Jun SH.

J Korean Med Sci. 2008 Jun;23(3):421-7. doi: 10.3346/jkms.2008.23.3.421.

19.

Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.

Al-Moundhri MS, Al-Nabhani M, Burney IA, Al-Farsi AA, Al-Bahrani B.

Mol Carcinog. 2009 Dec;48(12):1170-6. doi: 10.1002/mc.20572.

PMID:
19676106
20.

No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.

Onen IH, Konac E, Eroglu M, Guneri C, Biri H, Ekmekci A.

Mol Biol Rep. 2008 Mar;35(1):17-22. Epub 2007 Jan 11.

PMID:
17216542

Supplemental Content

Support Center